CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk› Healthcare› Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd

BSE 531633 LINCOLN INE405C01035
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 61 trading days

7 filings · 2 material · busiest 2026-08-13

What it files

Newspaper Publication2 Board Outcome1 Results1 Board Meeting1 Compliance Certificate1 Trading Window1

Filings

7 in the window

  1. 26 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement regarding the 32nd Annual General Meeting of the Company to be held on Wednesday, September 30, 2026.

    Company Update / Newspaper Publication View filing →

  2. 14 August 2026

    Newspaper Publication

    Newspaper Publication

    We enclosed herewith the copies of newspaper intimation with respect to the unaudited (standalone & Consolidated) Financial Results of the Company for the Quarter Ended 30 June, 2026.

    Company Update / Newspaper Publication View filing →

  3. 13 August 2026

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter Ended On June 30, 2026.

    Un-Audited Financial Results of the Company For the Quarter Ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  4. 13 August 2026

    Results

    Un-Audited Financial Results For Quarter Ended On 30 June, 2026.

    Un-Audited Financial Results For Quarter Ended on 30 June, 2026.

    Result / Financial Results View filing →

  5. 6 August 2026

    Board Meeting

    Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.

    Lincoln Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Lincoln Pharmaceuticals ....

    Board Meeting / Board Meeting View filing →

  6. 6 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation, 2018, we hereby submit the confirmation certificate received from MUFG Intime India Private Limited, ....

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  7. 24 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Trading Window Closure for the Quarter ended June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →